General
Preferred name
IODIXANOL
Synonyms
2-541O-3A ()
Visipaque 270 ()
Visipaque 320 ()
Visipaque ()
NSC-760069 ()
2-5410-3A ()
P&D ID
PD009938
CAS
92339-11-2
Tags
available
drug
Approved by
FDA
First approval
1996
Drug Status
approved
Max Phase
Phase 4
Drug indication
Diagnostic Aid (radiopaque medium)
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PHARMACODYNAMICS
Iodixanol is a contrast agent commonly used during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents. It is an imaging contrast agent with the same osmolality as blood (290mOsm/kg H20).
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
14
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
26
Molecular Weight
1549.71
Hydrogen Bond Acceptors
15
Hydrogen Bond Donors
13
Rotatable Bonds
22
Ring Count
2
Aromatic Ring Count
2
cLogP
-1.59
TPSA
339.09
Fraction CSP3
0.49
Chiral centers
4.0
Largest ring
6.0
QED
0.06
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
